Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder
Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.v60n0610
Authors: Marcio Versiani, Lembit Mehilane, Peter Gaszner, René Arnaud-Castiglioni, The Metrifonate Study Group
Institution: Universidade Federal do Rio de Janeiro
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2072962598
